Hepatic Cell News Volume 5.08 | Mar 5 2021

    0
    69






    HCN 5.08 | Mar 5 2021


    Hepatic Cell News by STEMCELL Technologies
    Vol. 5.08 – 5 March, 2021
    TOP STORY

    Proliferation Tracing Reveals Regional Hepatocyte Generation in Liver Homeostasis and Repair

    Cell proliferation tracing revealed that, at the whole hepatocyte–population level, more proliferation was detected in a subset of midzonal hepatocytes during liver homeostasis, with less proliferation in periportal hepatocytes and minimal proliferation in pericentral hepatocytes.
    [Science]

    Abstract

    Explore scientific events this March with the Science Events Calendar.
    PUBLICATIONSRanked by the impact factor of the journal

    Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis through m6A mRNA Methylation Dependent Mechanism

    The authors validated the increased N6‐methyladenosine (m6A) modification and elevated YTHDF1 protein level in sublethal‐heat‐treated hepatocellular carcinoma (HCC) cell lines, HCC patient‐derived xenograft mouse model and patients’ HCC tissues.
    [Hepatology]

    Abstract

    SIRT2 Prevents Liver Steatosis and Metabolic Disorders via Deacetylation of HNF4α

    Researchers found that Sirtuin 2 (SIRT2) was significantly downregulated in livers from advanced NAFLD patients and high‐fat diet (HFD)‐induced non-alcoholic liver disease mice. They revealed that SIRT2 was markedly decreased in obese mice and in palmitate‐treated HepG2 cells.
    [Hepatology]

    Abstract

    Deubiquitinase USP39 and E3 Ligase TRIM26 Balance the Level of ZEB1 Ubiquitination and Thereby Determine the Progression of Hepatocellular Carcinoma

    Scientists revealed that USP39 was highly expressed in human hepatocellular carcinoma (HCC) tissues and correlated with poor prognosis. USP39 depletion inhibited HCC cell proliferation and metastasis by promoting ZEB1 degradation.
    [Cell Death & Differentiation]

    Full Article

    BLOC1S1/GCN5L1/BORCS1 Is a Critical Mediator for the Initiation of Autolysosomal Tubulation

    The genetic reintroduction of BLOC1S1 rescued lysosomal tubulation in liver-specific knockout hepatocytes, but not when KIF5B was concurrently depleted.
    [Autophagy]

    Abstract

    Up-Regulation of miR-34b/C by Jnk and FOXO3 Protects from Liver Fibrosis

    Researchers investigated differential expression of microRNAs between PiZ and control mice and found that miR-34b/c was up-regulated and its levels correlated with intrahepatic Z α1-antitrypsin.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    Targeting EphA2 Suppresses Hepatocellular Carcinoma Initiation and Progression by Dual Inhibition of JAK1/STAT3 and AKT Signaling

    The authors discovered that targeting EphA2 suppressed both AKT and JAK1/STAT3 signaling, two separate oncogenic pathways in hepatocelllar carcinoma.
    [Cell Reports]

    Full ArticleGraphical Abstract

    The Protein Phosphatase PPM1A Dephosphorylates and Activates YAP to Govern Mammalian Intestinal and Liver Regeneration

    Genetic ablation or depletion of PPM1A in cells, organoids, and mice elicited an enhanced Yes-associated protein (YAP)/TAZ cytoplasmic retention and resulted in the diminished cell proliferation, severe gut regeneration defects in colitis, and impeded liver regeneration upon injury.
    [PLoS Biology]

    Full Article

    Gene Editing and Synthetically Accessible Inhibitors Reveal Role for TPC2 in HCC Cell Proliferation and Tumor Growth

    Investigators report that TPC2 knockout reduced proliferation of cancer cells in vitro, affected their energy metabolism, and successfully abrogated tumor growth in vivo.
    [Cell Chemical Biology]

    AbstractGraphical Abstract

    Hepatic HuR Protects against the Pathogenesis of Non-alcoholic Fatty Liver Disease by Targeting Pten

    Researchers investigated the level of human antigen R in the liver of mice fed a normal chow diet and a high-fat diet.
    [Cell Death & Disease]

    Full Article

    WW Domain-Binding Protein 2 Overexpression Prevents Diet-Induced Liver Steatosis and Insulin Resistance through AMPKβ1

    In vitro experiments showed that in the human normal hepatocyte cell line LO2 and primary hepatocytes isolated from mice, overexpression of WW domain-binding protein 2 (WBP2) reduced fat deposition, and knocking out or knocking down WBP2 aggravated PA-induced fat deposition.
    [Cell Death & Disease]

    Full Article

    FOXO3-Induced lncRNA LOC554202 Contributes to Hepatocellular Carcinoma Progression via the miR-485-5p/Bsg Axis

    Scientists reported that LOC554202 expression was distinctly upregulated in HCC specimens and cell lines.
    [Cancer Gene Therapy]

    Full Article

    Enter a contest to win a personalized lab coat by subscribing to Organoid News!
    REVIEWS

    Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

    The authors summarize currently available adult cell‐derived hepatobiliary organoid models and their applications.
    [Hepatology]

    Abstract

    Role of Fibroblast Growth Factor Signaling in Hepatic Fibrosis

    Scientists summarize the latest advances in the understanding of fibroblast growth factor signaling in hepatic fibrosis.
    [Liver International]

    Abstract

    INDUSTRY AND POLICY NEWS

    Tempest Therapeutics Announces Clinical Collaboration with Roche to Advance TPST-1120 into a Randomized Combination Study in First-line Hepatocellular Carcinoma

    Tempest Therapeutics, Inc. announced a clinical collaboration agreement with F. Hoffmann-La Roche Ltd. The collaboration will evaluate TPST-1120, Tempest’s small molecule PPAR⍺ antagonist, in combination with atezolizumab and bevacizumab in previously untreated patients with advanced hepatocellular carcinoma.
    [Tempest Therapeutics, Inc.]

    Press Release

    FEATURED EVENT

    European Immunogenetics and Histocompatibility Conference

    April 21 – 23, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Faculty and Postdoctoral Positions – Stem Cells and Cancer

    Shanghai Jiao Tong University School of Medicine- Shanghai, China

    Postdoctoral Scientist – Senescence and Cancer

    Cancer Research Center of Lyon – Lyon, France

    Senior Scientist – Assay Development

    CyberCoders – San Diego, California, United States

    Postdoctoral Fellow – p53 and Metabolism

    The Francis Crick Institute – London, England, United Kingdom

    Postdoctoral Associate – NAFLD and Hepatocellular Carcinoma

    Baylor College of Medicine – Houston, Texas, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter